source
- Isomorphic Labs secures $2.1 billion Series B, cementing AI drug-discovery leadershipIsomorphic Labs announced on Tuesday that it has closed a $2.1 billion Series B financing round. The sizable round underscores the company’s position as a bellwether for using artificial intellige…
- Bristol Myers Squibb partners with Hengrui Pharma in $15.2 billion, 13-asset dealBristol Myers Squibb announced a partnership with China’s Hengrui Pharma that includes 13 assets. The transaction is reported to be valued at up to $15.2 billion, highlighting the scale of collabo…